These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32774492)

  • 1. Clinical significance of herpes virus entry mediator expression in hepatitis B virus-related hepatocellular carcinoma.
    Yi Y; Ni XC; Liu G; Yin YR; Huang JL; Gan W; Zhou PY; Guan RY; Zhou C; Sun BY; Qiu SJ
    Oncol Lett; 2020 Oct; 20(4):19. PubMed ID: 32774492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Changes of BTLA and HVEM Expressions in Circulating CD4
    Liu J; Li J; He M; Zhang GL; Zhao Q
    J Immunol Res; 2018; 2018():4561571. PubMed ID: 30116751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
    Hokuto D; Sho M; Yamato I; Yasuda S; Obara S; Nomi T; Nakajima Y
    Eur J Cancer; 2015 Jan; 51(2):157-65. PubMed ID: 25468715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intrahepatic expression and distribution of BTLA and its ligand HVEM in patients with HBV-related acute-on-chronic liver failure.
    Xu H; Cao D; Guo G; Ruan Z; Wu Y; Chen Y
    Diagn Pathol; 2012 Oct; 7():142. PubMed ID: 23067542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of BTLA and HVEM Expression on Circulating CD4
    Song HF; Chen XJ; Tang PJ; Xu P; Huang ZY; Wang XF
    Viral Immunol; 2022 May; 35(4):291-302. PubMed ID: 35196150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection.
    Yu X; Zheng Y; Mao R; Su Z; Zhang J
    Front Immunol; 2019; 10():617. PubMed ID: 30984188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.
    Zhao Q; Zhang GL; Zhu X; Su D; Huang ZL; Hu ZX; Peng L
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1520-1524. PubMed ID: 27987232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection.
    Steinberg MW; Huang Y; Wang-Zhu Y; Ware CF; Cheroutre H; Kronenberg M
    PLoS One; 2013; 8(10):e77992. PubMed ID: 24205057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis.
    Lan X; Li S; Gao H; Nanding A; Quan L; Yang C; Ding S; Xue Y
    Onco Targets Ther; 2017; 10():919-926. PubMed ID: 28243127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
    Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
    Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer.
    Demerlé C; Gorvel L; Olive D
    Front Oncol; 2021; 11():682007. PubMed ID: 34532285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.
    Migita K; Sho M; Shimada K; Yasuda S; Yamato I; Takayama T; Matsumoto S; Wakatsuki K; Hotta K; Tanaka T; Ito M; Konishi N; Nakajima Y
    Cancer; 2014 Mar; 120(6):808-17. PubMed ID: 24249528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.
    Wang S; Ljubimov AV; Jin L; Pfeffer K; Kronenberg M; Ghiasi H
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice.
    Aubert N; Brunel S; Olive D; Marodon G
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection
    Wang S; Hirose S; Ghiasi H
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of herpes virus entry mediator is associated with poor prognosis in clear cell renal cell carcinoma.
    Tang M; Cao X; Li Y; Li GQ; He QH; Li SJ; Chen J; Xu GL; Zhang KQ
    Am J Cancer Res; 2019; 9(5):975-987. PubMed ID: 31218105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1
    Del Rio ML; de Juan CY; Roncador G; Caleiras E; Álvarez-Esteban R; Pérez-Simón JA; Rodriguez-Barbosa JI
    Front Immunol; 2023; 14():1113858. PubMed ID: 37033927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
    J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased granzyme-B expression in CD11c
    Gao L; Hong Z; Lei G; Guo AL; Wang FS; Jiao YM; Fu J
    Front Immunol; 2023; 14():1107483. PubMed ID: 36798119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.